Jeremiah Kelly

Jeremiah Kelly guides medical product companies through every stage of FDA regulation for drugs, biologics, medical devices, and combination products. He helps clients move from “bench to bedside” — from initial research and development through clinical trials, FDA applications, and post-market compliance, ensuring that products reach patients efficiently and remain commercially viable. Drawing on extensive FDA and DoD experience, Jeremiah delivers practical, strategic counsel that helps clients anticipate regulatory challenges, maximize opportunities, and stay compliant in a complex regulatory environment.